Although RUNX1-ETO and RUNX1-EVI1 carry the same DNA-binding domain and bind to the same motifs in vitro (Meyers et al., 1993, Tanaka et al., 1995), the two classes of AML have distinct clinical characteristics. This evidence concerns the gene RUNX1 and acute myeloid leukemia.